— Know what they know.
Not Investment Advice
Also trades as: HGENQ (OTC) · $vol 0M

HGEN NASDAQ

Humanigen, Inc.
1W: +0.0% 1M: -91.7% 3M: -95.0% 1Y: -99.9% 3Y: -100.0% 5Y: -100.0%
$0.00
Last traded 2024-01-30 — delisted
NASDAQ · Healthcare · Biotechnology

Balance Sheet Trends

Total Assets
$11M -84.2% ▼
5Y CAGR: +46.3%
Total Liabilities
$58M -38.8% ▼
5Y CAGR: +17.4%
Shareholders Equity
-$47M -97.4% ▼
Cash & Investments
$10M -85.5% ▼
5Y CAGR: +69.0%
Total Debt
$0 -100.0% ▼
Net Debt
-$10M +77.4% ▲

Assets vs Liabilities & Equity

Year-over-Year Growth

View Full Balance Sheet
Line ItemFY2018FY2019FY2020FY2021FY2022
— Assets —
Cash$814K$143K$68M$70M$10M
Short-Term Investments$0$0$0$0$0
Cash & ST Investments$814K$143K$68M$70M$10M
Net Receivables$0$0$0$0$0
Inventory$0$0$0$0$0
Other Current Assets$485K$309K$475K$955K$950K
Total Current Assets$1M$452K$68M$71M$11M
Property, Plant & Equip.$0$0$0$0$0
Goodwill & Intangibles$0$0$20K$0$0
Long-Term Investments$0$0$0$0$0
Other Non-Current Assets$71K$71K$70K$90K$90K
Total Non-Current Assets$71K$71K$90K$90K$90K
Total Assets$1M$523K$68M$71M$11M
— Liabilities —
Accounts Payable$3M$5M$15M$45M$41M
Short-Term Debt$2M$5M$0$0$0
Deferred Revenue$0$0$2M$4M$883K
Other Current Liabilities$3M$3M$5M$20M$15M
Total Current Liabilities$8M$14M$20M$69M$56M
Long-Term Debt$1M$1M$0$25M$0
Other Non-Current Liab.$0$0$0$0$0
Total Non-Current Liabilities$1M$1M$2M$26M$2M
Total Liabilities$9M$15M$23M$95M$58M
— Equity —
Common Stock$110K$114K$52K$64K$119K
Retained Earnings-$275M-$285M-$374M-$611M-$682M
Accumulated OCI$0$0$0$0$0
Total Stockholders Equity-$8M-$14M$46M-$24M-$47M
Total Liabilities & Equity$1M$523K$68M$71M$11M
— Key Metrics —
Total Debt$3M$6M$0$25M$0
Net Debt$3M$6M-$68M-$45M-$10M
Total Investments$0$0$0$0$0

Sign in to InsiderStreet

You'll also get our free weekly newsletter with
smart money signals, market insights, and alpha ideas.
Unsubscribe anytime.

For informational purposes only. Not investment advice. Data sourced from SEC filings. Privacy Terms